These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2179966

  • 1. Strain-dependent effects of phenobarbital on liver tumor promotion in inbred mice.
    Diwan BA, Rice JM, Ward JM.
    Prog Clin Biol Res; 1990; 331():69-83. PubMed ID: 2179966
    [Abstract] [Full Text] [Related]

  • 2. Promotion of malignant 'embryonal' liver tumors by phenobarbital: increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6)F1 mice initiated with N-nitrosodiethylamine.
    Diwan BA, Ward JM, Rice JM.
    Carcinogenesis; 1989 Jul; 10(7):1345-8. PubMed ID: 2472233
    [Abstract] [Full Text] [Related]

  • 3. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice.
    Diwan BA, Rice JM, Ohshima M, Ward JM.
    Carcinogenesis; 1986 Feb; 7(2):215-20. PubMed ID: 3948311
    [Abstract] [Full Text] [Related]

  • 4. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W, Chabicovsky M, Wastl U, Grasl-Kraupp B, Bukowska K, Taper H, Schulte-Hermann R.
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [Abstract] [Full Text] [Related]

  • 5. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J, Willecke K, Schwarz M.
    Cancer Res; 2000 Sep 15; 60(18):5087-91. PubMed ID: 11016633
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Angel JM, Caballero M, DiGiovanni J.
    Cancer Res; 2003 Jun 01; 63(11):2747-51. PubMed ID: 12782578
    [Abstract] [Full Text] [Related]

  • 8. Effect of phenobarbital on the development of liver tumors in juvenile and adult mice.
    Pereira MA, Klaunig JE, Herren-Freund SL, Ruch RJ.
    J Natl Cancer Inst; 1986 Aug 01; 77(2):449-52. PubMed ID: 3461205
    [Abstract] [Full Text] [Related]

  • 9. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice.
    Malkinson AM, Beer DS.
    J Natl Cancer Inst; 1983 May 01; 70(5):931-6. PubMed ID: 6573537
    [Abstract] [Full Text] [Related]

  • 10. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
    Iwai S, Murai T, Makino S, Min W, Morimura K, Mori S, Hagihara A, Seki S, Fukushima S.
    Cancer Lett; 2007 Feb 08; 246(1-2):115-21. PubMed ID: 16569478
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine.
    Lee GH, Ooasa T, Osanai M.
    Cancer Res; 1998 Apr 15; 58(8):1665-9. PubMed ID: 9563480
    [Abstract] [Full Text] [Related]

  • 12. Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine- and dimethylnitrosamine-initiated infant male mice.
    Weghorst CM, Pereira MA, Klaunig JE.
    Carcinogenesis; 1989 Aug 15; 10(8):1409-12. PubMed ID: 2752514
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice.
    Dragani TA, Manenti G, Della Porta G.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6299-303. PubMed ID: 1933890
    [Abstract] [Full Text] [Related]

  • 14. N-Nitroso-N-methylurea initiation in multiple tissues for organ-specific tumor promotion in rats by phenobarbital.
    Diwan BA, Palmer AE, Ohshima M, Rice JM.
    J Natl Cancer Inst; 1985 Dec 01; 75(6):1099-105. PubMed ID: 3865012
    [Abstract] [Full Text] [Related]

  • 15. Further evidence for promoter-dependent development of hepatoblastoma in the mouse.
    Diwan BA, Henneman JR, Rice JM.
    Cancer Lett; 1995 Feb 10; 89(1):29-35. PubMed ID: 7882299
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2) F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement.
    Naito M, Chenicek KJ, Naito Y, DiGiovanni J.
    Carcinogenesis; 1988 Apr 10; 9(4):639-45. PubMed ID: 3128409
    [Abstract] [Full Text] [Related]

  • 17. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
    Shirai T, Imaida K, Ohshima M, Fukushima S, Lee MS, King CM, Ito N.
    Jpn J Cancer Res; 1985 Jan 10; 76(1):16-9. PubMed ID: 2857671
    [Abstract] [Full Text] [Related]

  • 18. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice.
    Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR.
    Cancer Res; 2004 Oct 15; 64(20):7197-200. PubMed ID: 15492232
    [Abstract] [Full Text] [Related]

  • 19. Genetic background and development of skin tumors.
    Naito M, DiGiovanni J.
    Carcinog Compr Surv; 1989 Oct 15; 11():187-212. PubMed ID: 2493334
    [Abstract] [Full Text] [Related]

  • 20. Genetic and epigenetic promotion of murine hepatocarcinogenesis.
    Drinkwater NR, Hanigan MH, Kemp CJ.
    Prog Clin Biol Res; 1990 Oct 15; 331():163-76. PubMed ID: 2156269
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.